Cargando…

Cellular evasion strategies of Helicobacter pylori in regulating its intracellular fate

Helicobacter pylori colonizes human stomach mucosa and its infection causes gastrointestinal diseases with variable severity. Bacterial infection stimulates autophagy, which is a part of innate immunity used to eliminate intracellular pathogens. Several intracellular bacteria have evolved multiprong...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sit, Wei Yang, Chen, Yu-An, Chen, Yu-Lun, Lai, Chih-Ho, Wang, Wen-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102552/ https://www.ncbi.nlm.nih.gov/pubmed/32033828 http://dx.doi.org/10.1016/j.semcdb.2020.01.007

Ejemplares similares

Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion
por: Sijmons, Daniel, et al.
Publicado: (2022)

Probiotic Lactobacillus spp. Act Against Helicobacter pylori-induced Inflammation
por: Chen, Yi-Hsing, et al.
Publicado: (2019)

Compromised autophagy by MIR30B benefits the intracellular survival of Helicobacter pylori
por: Tang, Bin, et al.
Publicado: (2012)

Antibacterial activity of ovatodiolide isolated from Anisomeles indica against Helicobacter pylori
por: Lien, Hsiu-Man, et al.
Publicado: (2019)

Helicobacter pylori Treatment Strategies in Singapore
por: Ang, Tiing Leong, et al.
Publicado: (2021)

Statin Decreases Helicobacter pylori Burden in Macrophages by Promoting Autophagy
por: Liao, Wei-Chih, et al.
Publicado: (2017)

Helicobacter pylori cag Pathogenicity Island's Role in B7-H1 Induction and Immune Evasion
por: Lina, Taslima T., et al.
Publicado: (2015)

Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes
por: Wang, Jinfeng, et al.
Publicado: (2023)

Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection
por: Ho, Cheng-Yu, et al.
Publicado: (2022)

Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo
por: Lin, Yu-Hsin, et al.
Publicado: (2014)

Conclusive strategies for therapy and virotyping of Helicobacter pylori
por: Abadi, Amin T. B., et al.
Publicado: (2014)

Strategies for Helicobacter pylori eradication in the year 2020
por: Pellicano, Rinaldo, et al.
Publicado: (2020)

Emerging Role of Helicobacter pylori in the Immune Evasion Mechanism of Gastric Cancer: An Insight Into Tumor Microenvironment-Pathogen Interaction
por: Li, Zhifang, et al.
Publicado: (2022)

Intracellular fate of Ureaplasma parvum entrapped by host cellular autophagy
por: Nishiumi, Fumiko, et al.
Publicado: (2017)

A Culture-Based Strategy Is More Cost Effective Than an Empiric Therapy Strategy in Managing Pediatric Helicobacter pylori Infection
por: Hung, Chi-Wen, et al.
Publicado: (2022)

Helicobacter pylori Activates HMGB1 Expression and Recruits RAGE into Lipid Rafts to Promote Inflammation in Gastric Epithelial Cells
por: Lin, Hwai-Jeng, et al.
Publicado: (2016)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Metal-Based Nanoparticles: A Prospective Strategy for Helicobacter pylori Treatment
por: Yin, Xiaojing, et al.
Publicado: (2023)

Treatment of Pediatric Helicobacter pylori Infection
por: Lai, Hung-Hsiang, et al.
Publicado: (2022)

Helicobacter pylori inhibits autophagic flux and promotes its intracellular survival and colonization by down‐regulating SIRT1
por: Wang, Xin, et al.
Publicado: (2021)

Intracellular Presence of Helicobacter pylori and Its Virulence-Associated Genotypes within the Vaginal Yeast of Term Pregnant Women
por: Sánchez-Alonzo, Kimberly, et al.
Publicado: (2021)

Helicobacter pylori
por: Harris, A. W. (Adam W.), 1963-
Publicado: (1996)

Helicobacter Pylori
por: Aguilar Lasserre, Rubén
Publicado: (1998)

Helicobacter pylori Induces IL-33 Production and Recruits ST-2 to Lipid Rafts to Exacerbate Inflammation
por: Kuo, Chia-Jung, et al.
Publicado: (2019)

Mixed Infections of Helicobacter pylori Isolated from Patients with Gastrointestinal Diseases in Taiwan
por: Lai, Chih-Ho, et al.
Publicado: (2016)

In Response to “Conclusive Strategies for Therapy and Virotyping of Helicobacter Pylori”
por: Alvi, Ayesha
Publicado: (2014)

Strategies used by helicobacter pylori to establish persistent infection
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Maintenance of the Cell Morphology by MinC in Helicobacter pylori
por: Chiou, Pei-Yu, et al.
Publicado: (2013)

Helicobacter pylori recrudescence and its influencing factors
por: Sun, Yan, et al.
Publicado: (2019)

Helicobacter pylori and Its Role in Gastric Cancer
por: Reyes, Victor E.
Publicado: (2023)

Statins’ Regulation of the Virulence Factors of Helicobacter pylori and the Production of ROS May Inhibit the Development of Gastric Cancer
por: Lin, Ting-Yu, et al.
Publicado: (2021)

Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles
por: Jiang, Liqin, et al.
Publicado: (2013)

Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers
por: Mazumdar, Samrat, et al.
Publicado: (2021)

Changes in the Treatment Strategies for Helicobacter pylori Infection in Children and Adolescents in Korea
por: Jun, Jin-Su, et al.
Publicado: (2019)

Helicobacter pylori in the Oral Cavity: Current Evidence and Potential Survival Strategies
por: Zhang, Lin, et al.
Publicado: (2022)

Sugar-Rich Foods Carry Osmotolerant Yeasts with Intracellular Helicobacter Pylori and Staphylococcus spp
por: Siavoshi, Farideh, et al.
Publicado: (2020)

Enhanced enzymatic production of cholesteryl 6ʹ-acylglucoside impairs lysosomal degradation for the intracellular survival of Helicobacter pylori
por: Muthusamy, Sasikala, et al.
Publicado: (2021)

Cortactin: A Major Cellular Target of the Gastric Carcinogen Helicobacter pylori
por: Sharafutdinov, Irshad, et al.
Publicado: (2020)

Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis
por: Palrasu, Manikandan, et al.
Publicado: (2022)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2fhq985sp4nr14vn7k0rd63g6j